Making Moves In The Community, Incorporated Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1305 Martin Luther King, Shelby, MS 38774 Phone: 662-402-1098 |
Diabet-eez Of Shelby Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1207 Broadway S, Shelby, MS 38774 Phone: 662-357-3883 |
Hl Campbell Rural Health Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 901 Forest Street, Shelby, MS 38774 Phone: 662-398-5004 |
Shelby Family And Specialty Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 1207 Broadway S, Shelby, MS 38774 Phone: 662-357-3883 |
News Archive
The National Multiple Sclerosis Society has announced that the esteemed actor and comedienne Teri Garr has been named the first National Chair of their Women Against MS (WAMS) program.
Deerfield Management Company announced today that it has provided up to $250 million in acquisition financing to Horizon Pharma, Inc. for the acquisition of Vidara Therapeutics International Ltd.
As if the rollout of the federal health law didn't have enough problems, abortion is back in the spotlight. How the various health plans in the exchanges would or would not pay for abortion was one of the very last issues settled before the bill was passed in 2010. Now abortion's invisibility on the federal HealthCare.gov website has some people pretty upset (Rovner, 11/1).
Many researchers have studied the relationship between the increase in sales of new antidepressants in recent decades and a simultaneous decline in the suicide rate. In a study based on figures from the Nordic countries, researchers at the Norwegian Institute of Public Health found no evidence that increased sales of the new medicines could be linked to a lower suicide rate. The researchers also did not find any relationship between reduced sales of the older and more toxic antidepressants and a reduction in suicide rates.
OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced the completion of patient enrollment in a Phase II clinical trial of ImmunoPulse for metastatic melanoma patients.
› Verified 3 days ago